Cargando…
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
BACKGROUND: Targeting negatively charged mitochondria is often achieved using triphenylphosphonium (TPP) cations. These cationic vehicles may possess biological activity, and a docking study indicates that TPP-moieties may act as modulators of signaling through the estrogen receptor α (ERα). Moreove...
Autores principales: | Zinovkina, Ludmila A., Galivondzhyan, Alina K., Prikhodko, Anastasia S., Galkin, Ivan I., Zinovkin, Roman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102506/ https://www.ncbi.nlm.nih.gov/pubmed/32257641 http://dx.doi.org/10.7717/peerj.8803 |
Ejemplares similares
-
Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis
por: Andreev-Andrievskiy, Alexander A., et al.
Publicado: (2016) -
Mitochondria as Targets for Endothelial Protection in COVID-19
por: Chernyak, Boris V., et al.
Publicado: (2020) -
Docking study of triphenylphosphonium cations as estrogen receptor α modulators
por: Salisbury, Joseph P, et al.
Publicado: (2009) -
Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants
por: Jameson, Victoria J.A., et al.
Publicado: (2015) -
COVID-19 and Oxidative Stress
por: Chernyak, B. V., et al.
Publicado: (2020)